CELG Stock UPDATES Celgene Corp (CELG) 88.46 08/14/2014 19:3
Post# of 273333
Posted On: 08/14/2014 8:32:52 PM
Celgene Corp (CELG) 88.46 $CELG
Final Glance: Biotechnology companies
AP - 2 hrs 30 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Midday Glance: Biotechnology companies
AP - Thu Aug 14, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Early Glance: Biotechnology companies
AP - Thu Aug 14, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers
After Yesterday's Rally of 2.27% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Aug 13, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $86.56 to a high of $88.76. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $87.51 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock
at The Street - Wed Aug 13, 10:45AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna
PR Newswire - Tue Aug 12, 7:40AM CDT
Today, Analysts Review released its research reports regarding Actavis PLC (NYSE: ACT), UnitedHealth Group Inc. (NYS: UNH), Bristol-Myers Squibb Co. (NYSE: BMY), Celgene Corporation (NASDAQ: CELG) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5652-100free.
Jim Cramer's 'Mad Money' Recap: Controlling Your Destiny
at The Street - Mon Aug 11, 7:03PM CDT
When you can't spur growth internally, you can make an acquisition, Cramer says.
Celgene Earnings In Retrospect: Up 0.4% in the Last 18 Days (CELG)
Comtex SmarTrend(R) - Mon Aug 11, 11:39AM CDT
18 days ago, on July 24th, 2014, Celgene (NASDAQ:CELG) reported its earnings. Analysts, on average, expected earnings of $0.89 per share on sales of $1.8 billion. The company actually reported EPS of $0.90 on sales of $1.9 billion, beating EPS estimates by $0.01 and beating revenue estimates by $27.6 million. Since the company's report, shares of Celgene have risen from $86.19 to $86.51, representing a gain of 0.4% in the past 18 days.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Aug 08, 7:15PM CDT
Cramer's watching earnings next week as he seeks stocks worth buying, not selling, in this market.
Celgene Shares Up 15.6% Since SmarTrend's Buy Recommendation (CELG)
Comtex SmarTrend(R) - Fri Aug 08, 9:51AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 3 months, Celgene has returned 15.64% as of today's recent price of $85.50.
Final Glance: Biotechnology companies
AP - 2 hrs 30 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Midday Glance: Biotechnology companies
AP - Thu Aug 14, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Early Glance: Biotechnology companies
AP - Thu Aug 14, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers
After Yesterday's Rally of 2.27% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Aug 13, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $86.56 to a high of $88.76. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $87.51 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock
at The Street - Wed Aug 13, 10:45AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna
PR Newswire - Tue Aug 12, 7:40AM CDT
Today, Analysts Review released its research reports regarding Actavis PLC (NYSE: ACT), UnitedHealth Group Inc. (NYS: UNH), Bristol-Myers Squibb Co. (NYSE: BMY), Celgene Corporation (NASDAQ: CELG) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5652-100free.
Jim Cramer's 'Mad Money' Recap: Controlling Your Destiny
at The Street - Mon Aug 11, 7:03PM CDT
When you can't spur growth internally, you can make an acquisition, Cramer says.
Celgene Earnings In Retrospect: Up 0.4% in the Last 18 Days (CELG)
Comtex SmarTrend(R) - Mon Aug 11, 11:39AM CDT
18 days ago, on July 24th, 2014, Celgene (NASDAQ:CELG) reported its earnings. Analysts, on average, expected earnings of $0.89 per share on sales of $1.8 billion. The company actually reported EPS of $0.90 on sales of $1.9 billion, beating EPS estimates by $0.01 and beating revenue estimates by $27.6 million. Since the company's report, shares of Celgene have risen from $86.19 to $86.51, representing a gain of 0.4% in the past 18 days.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Aug 08, 7:15PM CDT
Cramer's watching earnings next week as he seeks stocks worth buying, not selling, in this market.
Celgene Shares Up 15.6% Since SmarTrend's Buy Recommendation (CELG)
Comtex SmarTrend(R) - Fri Aug 08, 9:51AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 3 months, Celgene has returned 15.64% as of today's recent price of $85.50.
(0)
(0)